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Immune inhibitor A(InhA)-typemetallopeptidases are
potential virulence factors secreted by members of
the Bacillus cereus group. Two paralogs from
anthrax-causing Bacillus anthracis (BaInhA1 and
BaInhA2) were shown to degrade host tissue pro-
teins with broad substrate specificity. Analysis of
their activation mechanism and the crystal structure
of a zymogenicBaInhA2 variant revealed a750-res-
idue four-domain structure featuring a pro-peptide, a
catalytic domain, a domain reminiscent of viral enve-
lope glycoproteins, and a MAM domain grafted into
the latter. This domain, previously found only in eu-
karyotes, is required for proper protein expression
in B. anthracis and evinces certain flexibility. Latency
is uniquely modulated by the N-terminal segment of
the pro-peptide, which binds the catalytic zinc
through its a-amino group and occupies the primed
side of the active-site cleft. The present results
further our understanding of the modus operandi of
an anthrax secretome regulator.
INTRODUCTION
Bacillus anthracis is a facultative anaerobic Gram-positive
spore-forming bacterium that belongs to the Bacillus cereus
group (BCG) of Bacillales (Rasko et al., 2005). In 1876, Robert
Koch identified it as the etiologic agent of anthrax (Koch,
1876), an ancient disease believed to have originated in Egypt
and Mesopotamia around 1250 BC, which might have been
among the ten plagues of Egypt (Sternbach, 2003). Anthrax is
an acute, rapidly progressing infectious disease that affects
humans and other animals (Baillie and Read, 2001), and infection
occurs through the spores, which produce three clinical pictures
depending on the entry pathway: cutaneous, inhalational, or
gastrointestinal anthrax. The former leads to skin ulcers,
which are generally easy to treat. In contrast, inhalational andStructure 24gastrointestinal anthrax are invasive and systemic, and often
fatal. Accordingly, novel therapeutic approaches targeting
B. anthracis are of importance and currently under investigation
(Artenstein and Opal, 2012).
In addition to the major virulence factors of B. anthracis iden-
tified, namely the plasmid-encoded anthrax toxin and the poly-
D-glutamic acid capsule, other proteins contribute to virulence
and disease, and may provide targets for therapy against
anthrax (Artenstein and Opal, 2012). Among candidate virulence
factors are immune inhibitor A (InhA) peptidases, which belong
to the thuringilysin family within themetzincin clan ofmetallopep-
tidases (MPs) (Cerda`-Costa and Gomis-Ru¨th, 2014). They have
also been ascribed to family M6 in the MEROPS proteolytic
enzyme database (http://merops.sanger.ac.uk). Metzincins
are characterized by a globular catalytic domain (CD) spanning
130–270 residues, which consists of a structurally conserved
N-terminal upper subdomain (NTS) and a lower, structurally
more disparate C-terminal subdomain (CTS). The two subdo-
mains are separated by the active-site cleft. NTSs span a
(mostly) five-stranded b sheet, a backing helix, and an active-
site helix, which contains an extended metal-binding motif,
HEXXHXX(G,N)XX(H,D). This motif encompasses three metal-
binding residues (in bold) and the catalytic general base/acid
glutamate (in italics) required for reaction. Some metzincins
also include an additional adamalysin helix, first described in
adamalysins/ADAMs (Cerda`-Costa and Gomis-Ru¨th, 2014).
Downstream CTSs mainly share a conserved loop with a central
methionine, the Met-turn, which provides a hydrophobic basis
for the metal-binding site (Tallant et al., 2010), and a C-terminal
helix. Among the 12 metzincin families structurally characterized
are the toxilysins (Cerda`-Costa and Gomis-Ru¨th, 2014; Gomis-
Ru¨th, 2013; Ng et al., 2013), which are part of the bacterial AB5
toxins (Beddoe et al., 2010). Like the protective antigen and le-
thal factor tandem in B. anthracis anthrax toxin, AB5 toxins
from Escherichia coli (EcxAB) and Citrobacter freundii (CfxAB)
consist of a subunit for host-cell invasion (pentameric subunit
B) and an active MP that subverts intracellular functions (subunit
A) (Beddoe et al., 2010).
The thuringilysins are one of the oldest known MP families, as
the founding member, InhA1 from Bacillus thuringiensis, was
identified in the mid-1970s as an immune inhibitor that interferes, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 25
Figure 1. Phylogenetic Analysis and
Sequence Alignment of Thuringilysins
(A) Phylogenetic tree of selectedBacillus (InhA) and
Vibrio (PrtV) thuringilysins, each with its UniProt
code. The bar represents 0.1 substitutions per site.
The tree shows three major groups of InhA pepti-
dases: A1 (magenta), A2 (green), and A3 (blue).
(B) Sequence alignment of BaInhA1 (UniProt:
Q81TI0) and BaInhA2 (UniProt: D8H130). Signal
peptides are in yellow, pro-peptides in orange,
catalytic domains in blue, VEG domains in green,
and MAM domains in red. Identical residues are
shown over dark background. Autolytic cleavage
sites are indicated by scissors (in blue, this work; in
magenta, see Chung et al., 2006). Residues
involved in zinc coordination and catalysis, as well
as in the Met-turn, are boxed in red. Residues of
BaInhA2 cloned from B. anthracis strain Ames 33
(this work) that differ from those deposited (strain
CI, UniProt: D8H130) are coloredmagenta. Regular
secondary structure elements of the BaInhA2
structure are shown.
See also Figure S3.with the humoral defense system of saturniid pupae in the hemo-
lymph by degrading antibacterial insect proteins (Edlund et al.,
1976). Close homologs with >60% pairwise sequence identity,
including InhA1, InhA2, and InhA3 paralogs, are found within
BCGmembers (Charlton et al., 1999), and a possible explanation
for this paralogy seems to be complementary expression
patterns during the distinct stages of the Bacillus life cycle
(Guillemet et al., 2010). Slightly more distant thuringilysin family
members (Gomis-Ru¨th, 2003) include PrtV peptidases from
several Vibrio species, including human pathogenic Vibrio
cholerae (VcPrtV; Vaitkevicius et al., 2008) and Vibrio parahae-
molyticus, which show >40% sequence identity with Bacillus
counterparts (Figure 1A).
Among thuringilysins are also InhA1 and InhA2 from
B. anthracis (BaInhA1 and BaInhA2, respectively). These are
synthesized as pre-pro-peptidases of 795 and 799 residues,26 Structure 24, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reservedrespectively (69% sequence identity; Fig-
ure 1B), with signal peptides (SPs) for
secretion of the zymogenic forms. Extra-
cellular activation of the latter prevents
damage to the bacterium. In general, the
transcription levels of inhA1 are 50–100
times higher than those of inhA2, which
can be explained by the presence of a
PlcR-binding site upstream of the pro-
moter region of the latter gene (McKenzie
et al., 2014).BaInhA1 is highly abundant in
supernatants of cultures grown under
either aerobic or anaerobic conditions
(Chitlaru et al., 2006), which can be found
in soil environment or within mammalian
host tissues during infection. BaInhA1
modulates, directly or indirectly, the form
and abundance of more than half of the
secreted proteins of B. anthracis (Pflugh-
oeft et al., 2014). In addition, it participatesin nutrient acquisition by digesting host-serum proteins such as
hemoglobin (Terwilliger et al., 2015). As to its function as a candi-
date virulence factor, BaInhA1 contributes to anthrax pathology
through direct degradation of host tissues: it cleaves various
extracellular matrix proteins (Chung et al., 2006), regulates adhe-
sion in human endothelial cells (Tonry et al., 2012), and increases
the blood-brain barrier disruption associated with anthrax
meningitis (Mukherjee et al., 2011). This MP also affects the
coagulation cascade by degrading thrombin-activatable fibrino-
lysis inhibitor, von Willebrand factor, plasma ADAMTS-13, pro-
thrombin, and factor X, among others (Chung et al., 2011).
To better understand the function of thuringilysins, we exam-
ined activation and proteolytic activity of BaInhA1 and BaInhA2
peptidases in vitro, and found that both were competent MPs
of broad specificity against proteins and peptides. We further
determined the crystal structure of the BaInhA2 zymogen, which
Figure 2. Activation and Stability of BaInhA1
and BaInhA2 Peptidases
(A) SDS-PAGE of WT, single mutant (E/A), and
double (HE/AA) mutants of BaInhA1 and BaInhA2.
Lane 1, molecular mass standard (mms). Lane 2,
culture supernatant of WT BaInhA1 (similar results
for WT BaInhA2). Lanes 3, 5, 7, 9, and 11, WT
BaInhA1, BaInhA1-E/A, BaInhA1-HE/AA, WT
BaInhA2, and BaInhA2-E/A, respectively, after af-
finity purification. Lanes 4, 6, 8, 10, and 12, WT
BaInhA1, BaInhA1-E/A, BaInhA1-HE/AA, WT
BaInhA2, and BaInhA2-E/A, respectively, after SEC
and incubation either at room temperature (WT) or
4C (mutants) for autolytic maturation.
(B) Autolytic processing ofBaInhA1-E/A and -HE/AA
mutants. Lane 1, mms. Lane 2, BaInhA1-E/A. Lane
3,BaInhA1-HE/AA (both at 0.2mg/ml) after SEC and
incubation at 4C.
(C) Correlation between bands observed in (A) and
domain structure of BaInhA1 and BaInhA2 (same
colors as in Figure 1B). The autolytic events are
labeled with gray numbers as in (A). Sequences
according to UniProt: Q81TI0/D8H130.
(D) Limited proteolysis of BaInhA1-E/A. Lane 1,
mms. Lanes 2–4, protein incubated at 1:100 pepti-
dase/substrate weight ratio with trypsin, chymo-
trypsin, and thermolysin, respectively. Lanes 5 and
6, protein incubated with trypsin and thermolysin,
respectively, at a 10:1 weight ratio.
(E and F) Circular dichroism spectra of mature WT
BaInhA1 and BaInhA2 (lanes 4 and 10 in A,
respectively) at 25C (E). Unfolding transition curves
showing temperature-dependent change in fluo-
rescence (F) and in circular dichroism signal at
215 nm (inset in E) for both mature proteins.
See also Figure S1.revealed four distinct domains and a novel mechanism of latency
among MPs. Taken together, these data shed light on the la-
tency, activation, and activity of the peptidase family and, thus,
lay the foundation for specific drug design against anthrax.
RESULTS AND DISCUSSION
Recombinant Production and Autolytic Activation
of B. anthracis InhA1/A2 Peptidases
Heterologous expression trials of several constructs in E. coli
(see Supplemental Experimental Procedures) yielded insoluble
protein under all conditions tested. We circumvented this prob-
lemby producing full-lengthBaInhA1 (84 kDa; residues E32–R795;
UniProt: Q81TI0; residues numbered in subscript) and BaInhA2
(85 kDa; residues E33–R799; UniProt: D8H130; residues
numbered in superscript) lacking the predicted endogenous
SPs in a Bacillus subtilis strain deficient in eight proteases with
a vector that provides a Bacillus SP for extracellular secretion
instead. Recombinant wild-type (WT) BaInhA1 and BaInhA2 un-
derwent fast stepwise processing (Figure 2A). This was strongly
diminished inBaInhA1 andBaInhA2 active-sitemutants, in which
the catalytic glutamates were replaced by alanine, thus resultingStructure 24in residual activity only (E/A mutants; Figure 2A); and was
completely abolished in a double-point mutant affecting both
the catalytic glutamate and a zinc-binding histidine of BaInhA1,
which was inactive (HE/AA mutant; Figure 2A). This indicated
that processing was autolytic, as previously described for other
recombinant bacterial MPs upon purification and concentration,
such as karilysin from Tannerella forsythia (Cerda`-Costa et al.,
2011), fragilysin-3 from Bacteroides fragilis (Goulas et al.,
2011), and snapalysin from Streptomyces coelicolor (Trillo-
Muyo et al., 2013).
Analysis of purified BaInhA1 and BaInhA2 by SDS-PAGE,
combined with N-terminal sequencing and mass spectrometry
(see Supplemental Experimental Procedures), revealed several
species spanning between 18 and 84/85 kDa (BaInhA1/BaInhA2;
Figures 2A and 2B). In particular, the latter species (circled 1 in
Figures 2A and 2C), with disordered N-terminal segments as
predicted by bioinformatics and indicated by small-angle
X-ray scattering studies (SAXS) in solution (see below), were
transformed over time into stable zymogens (circled 2 in Figures
2A and 2C) after cleavage before H46 and N
50, respectively.
This was the form that crystallized for BaInhA2 (see below).
A second series of cleavages removed the zymogenic, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 27
pro-peptides (H46–A129 and N
50–E133, respectively; for refer-
ence, mature purified BaInhA1 starts at T130; Chung et al.,
2006; see Figures 2A and 2C) plus some extra residues of the
mature moiety. This led to the single-chain mature forms (circled
3 in Figures 2A and 2C), which were equivalent to purified natural
BaInhA1 and BaInhA2, respectively. Finally, subsequent cleav-
ages, most notably one before V630 and V
634, respectively
(Figures 2A and 2C), resulted in the final mature forms, which
consisted of two non-covalently associated fragments of
46/55 kDa (BaInhA1/BaInhA2) and 18 kDa (circled 4 and 5,
plus 6 in Figures 2A and 2C). The two fragments that build up
the final mature forms (46 + 18 kDa in BaInhA1, consistent with
purified protein from B. anthracis extracts, see Chung et al.,
2006; and 55 + 18 kDa in BaInhA2) separated in SDS-PAGE
but not in size-exclusion chromatography (SEC), i.e. they
strongly but non-covalently associated. The activation of
BaInhA1 and BaInhA2, however, may follow a heterolytic mech-
anism in vivo triggered by other secreted bacterial peptidases or
host peptidases at the site of infection. Indeed, limited proteoly-
sis of BaInhA1 E/A mutant with trypsin, chymotrypsin, and ther-
molysin likewise resulted in pro-peptide removal (Figure 2D).
Importantly, the final mature forms obtained from B. subtilis
evinced a well-folded conformation as assessed by circular di-
chroism, which showed similar spectra and denaturation for
both BaInhA1 and BaInhA2 (Figure 2E). Their stability in front of
denaturation was further examined by the thermofluor approach,
which revealed no dye binding to the former and a temperature
of mid-transition of 52C for the latter (Figure 2F).
Proteolytic Activity and Inhibition of B. anthracis
InhA1/A2
Mature recombinant BaInhA1 and BaInhA2 efficiently digested
natural protein substrates including casein, fibrinogen, fibro-
nectin, actin, and gelatin, but not BSA or a-lactalbumin, which
is a highly stable multi-disulfide protein (Figure 3A). BaInhA1
further digested b-lactoglobulin and, notably, the major struc-
tural component of the mucus, MUC2 mucin, which covers
and protects the epithelium of the intestine from bacteria (Jo-
hansson et al., 2013). MUC2 mucin was cleaved with a profile
similar to that of the human intestinal MP meprin b (compare
Figure 3A, lower right and Figure 2 in Schutte et al., 2014).
Thus, BaInhA1 could have a role in the disruption of the dense
gel that mucins form, permitting anthrax to overcome this
gastrointestinal barrier and attack the intestinal epithelium during
infection. BaInhA1 further digested authentic triple-helical
collagen at multiple sites like a bona fide collagenase, thus
breaking down a structural protein that may be crucial to all three
anthrax infection processes. BaInhA1 was more active than
BaInhA2 against all protein substrates analyzed. This also held
for fluorogenic casein and gelatin, which were cleaved by BaI-
nhA1 5-fold more efficiently than by BaInhA2 (Figure 3C). WT
BaInhA1 and BaInhA2 were also overproduced extracellularly
by a B. anthracis strain deficient in six proteases (Pomerantsev
et al., 2011), and they showed equivalent activity to that of the
proteins expressed in B. subtilis on fluorogenic casein (Figures
2C, S1A, and S1D). As to peptidolytic activity, BaInhA1 cleaved
peptide Mca-R-P-K-P-V-E-Nva-W-R-K(dnp)-NH2 with high effi-
ciency and Mca-P-L-A-Nva-Dap(dnp)-A-R-NH2 less efficiently,
whereas BaInhA2 only digested the former. The rest of peptides28 Structure 24, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rightstested were not affected with the exception of Abz-V-K-F-Y-D-I-
K(dnp), which was digested by BaInhA1, thus suggesting broad
specificity, in particular against peptides. In addition, both
B. anthracis proteins displayed maximum proteolytic activity at
pH 6.5 (Figure 3D), which slightly deviates from previous results
with purifiedBaInhA1 (pH 7–8; Chung et al., 2006). TheMPswere
inhibited only by general MP inhibitors but not by specific inhib-
itors of other MPs or peptidase classes (Table S2), and by the
universal pan-peptidase inhibitor a2-macroglobulin (Figure 3B).
Accordingly, recombinantBaInhA1 andBaInhA2were compe-
tent MPs, which showed overall broad cleavage specificity
against proteins and peptides, as also found during autolytic
activation (see above) and in natural purified BaInhA1 protein
(Chung et al., 2006). This broad specificity is consistent with
the function of BaInhA1 in the B. anthracis secretome, where
it digests not only endogenous toxins (protein antigen, lethal
factor, and edema factor) and other peptidases (thermolysin
Npr599), but also multiple chitinases and chitin-binding pro-
teins which enable bacteria to thrive in the soil (Pflughoeft
et al., 2014).
Overall Structure of B. anthracis InhA2 Zymogen
A number of constructs and mutants of BaInhA1 and BaInhA2
were assayed for crystallization, but only BaInhA2 E/A mutant
zymogen (hereafter pro-BaInhA2-E/A) crystallized adequately
for structure analysis. However, given the high sequence identity
between the two paralogs (69%; see Figure 1B), the structure-
derived findings hereafter may be valid for both. The structure
was solved by a two-wavelength anomalous dispersion experi-
ment with a selenomethionine (SeMet) derivative, and final
models were obtained and refined against derivative data to
2.9 A˚ and native data to 2.6 A˚ resolution, respectively (see Table
1). Overall, structural information is available for two molecules
(A and B) from the native crystals and two from the derivative
(A and B). Given that molecule A of the native structure is the
most complete of the four (see Supplemental Experimental Pro-
cedures), it is taken as a reference hereafter. This molecule
spans the full segment N50-R799 and displays maximal overall di-
mensions of 70 A˚ (height) 3 85 A˚ (width) 3 65 A˚ (depth) (Figures
4A and 4B). It consists of four domains: the N-terminal pro-pep-
tide (N50–E133), a metzincin-type CD (Q134–A442), a VEG domain
(K443–P480 + H644–R799; for acronym explanation, see below),
and MAM (a domain previously described in meprin a and b,
A5 protein, and receptor-type tyrosine-protein phosphatase m)
(G481–A643), grafted into VEG (see Figure 4C).
Pro-peptide and Catalytic Domain of Pro-BaInhA2-E/A
The polypeptide chain starts on the primed side of the active-site
cleft with N50, the first of the 85 residues of the pro-peptide. The
chain runs in extended conformation along the cleft in the direc-
tion of a true substrate for its first four residues (Figures 4D and
4E). Thereafter, the chain features a small globular moiety
framed by two helices (a1 and a2; see Figure 1B). After helix
a2, the polypeptide runs across the non-primed side of the cleft
and reaches helix a3 at its leftmost end. This helix runs down-
ward along the left molecular surface and reaches the final
maturation cleavage point (E133–Q134) in the lower back part of
the molecule, on top of the VEG domain (see below and Fig-
ure 4D). This segment, including a3, is flexible andmostly absentreserved
Figure 3. Proteolytic Activity of BaInhA1 and BaInhA2
(A) Protein substrates in the absence and presence of mature WT BaInhA1 or BaInhA2 produced in B. subtilis. Reactions were carried out overnight at either 1:10
(collagen) or 1:50 (rest of substrates) enzyme/substrate weight ratios. Mucin was incubated at weight ratios of 1:50 (a) and 1:10 (b). Asterisks indicate bands
corresponding to final autolytic products of the peptidases.
(B) Proteolysis of fluorogenic casein over time by BaInhA1 (at 0.01 mg/ml) or BaInhA2 (0.1 mg/ml) produced inB. subtilis. Both proteins were further incubated with
human a2-macroglobulin (a2M) at an enzyme/inhibitor molar ratio of 1:2.
(C) Proteolytic activity on fluorogenic casein ofWT,mutant, andMAM-deleted variants ofBaInhA1 andBaInhA2 produced inB. anthracis (all at 0.01 mg/ml). Values
from triplicate reactions were averaged and standard deviations calculated.
(D) pH Dependence of BaInhA1 and BaInhA2 cleavage activity.(from G89–E95 to P132–L143) in three of the four molecules of the
two structures solved.
At Q134, the chain enters the CD (see Figures 4A–4C), which
with 309 residues is the longest of any metzincin described to
date and is subdivisible into an NTS (Q134–G386) and a CTS
(L387–A442; see Figure 4C). The first 22 residues of the NTS creep
upward along the back molecular surface interacting with the
VEG domain. At R162, the polypeptide enters the first strand
(b1) of the metzincin-characteristic five-stranded b sheet (top
to bottom, b4+b5[-b1[-b6[-b9[-b7Y). Downmost strand b7
is antiparallel to the others and creates the upper rim of the
active-site cleft, which has a slightly electronegative character
(Figure 4E). In metzincins, a backing helix connects the strandsStructure 24topologically equivalent to b1 and b4+b5. Here, this helix is
divided into two (a4 and a5) by a protrusion of the polypeptide
featuring a b ribbon (strands b2 and b3), which contributes to
the right back surface. Additional elements decorate the central
NTS b sheet. Among these, an adamalysin helix (a7) nestles on
top of the b sheet and connects b4+b5 with b6. Helix a7 is pre-
ceded by a short upstream helix a6 and loop (A252–G265), which
contributes to a calcium site (site 1) together with Lb6b7 (G317–
S334; Figure 5A). These two loops constitute a bulge, which pro-
trudes from the molecular surface above the cleft on its primed
side. Downstream of helix a7, a long loop (G281–H310) includes
310-helix h1 and shapes the left side of the molecule. This
loop, hereafter the calcium-binding loop, is stabilized by two, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 29
Table 1. Crystallographic Data
Dataset BaInhA2-E/A (Native) BaInhA2-E/A (SeMet, Peak) BaInhA2-E/A (SeMet, Peak)a
BaInhA2-E/A
(SeMet, Remote)a
Space group C2 P212121 P212121 P212121
Cell constants a, b, c (A˚), b () 177.0, 108.9, 100.4, 119.1 97.6, 102.4, 242.9, 90.0 97.6, 102.4,
242.9, 90.0
97.2, 102.1,
242.3, 90.00
Wavelength (A˚) 0.97934 0.97926 0.97926 0.93923
No. of measurements/unique
reflections
348,116/51,133 457,866/54,813 459,055/104,066 731,055/103,236
Resolution range (A˚)
(outermost shell)b
47.7–2.60 (2.74–2.60) 48.8–2.90 (3.07–2.90) 48.8–2.90 (3.07–2.90) 48.6–2.90 (3.06–2.90)
Completeness (%) 99.5 (99.2) 99.8 (99.8) 99.8 (99.8) 100.0 (100.0)
Rmerge
c 0.105 (0.956) 0.114 (0.672) 0.097 (0.630) 0.159 (1.075)
Rrim (= Rmeas)
d/CC1/2
d 0.113 (1.036)/0.998 (0.746) 0.121 (0.715)/0.998 (0.942) 0.111 (0.716)/
0.997 (0.876)
0.172 (1.161)/
0.996 (0.793)
Average intensitye 14.8 (2.1) 15.2 (4.2) 13.4 (3.1) 11.2 (2.1)
B Factor (Wilson)
(A˚2)/average multiplicity
55.6/6.8 (6.7) 54.4/8.4 (8.5) 54.7/4.4 (4.4) 55.9/7.1 (7.0)
Anomalous Corr.e/
SigAnoe/Nanoe
–/–/– –/–/– 47/1.30/49,083 30/1.00/48,942
Resolution range used
for refinement (A˚)
47.7–2.60 42.5–2.90
No. of reflections used
(test set)
51,130 (729) 54,706 (706)
Crystallographic R factor
(free R factor)c
0.171 (0.211) 0.182 (0.207)
No. of protein atoms/solvent
molecules/neutral (covalent)
ligands/ionic ligands
11,399/168/3 acetonitrile/2
Zn2+, 9 Ca2+, 2 K+, 2 Na+
10,763/104/2 sulfobetaine,
6 glycerol/2 Zn2+,
8 Ca2+, 2 K+
Root-mean-square deviation from target values
Bonds (A˚)/angles () 0.010/1.15 0.010/1.14
Average B factors (A˚2) 61.2 71.8
All-atom contacts and geometry analysisf
Residues
In favored regions/outliers/
all residues
1,400 (96.2%)/
9 (0.6%)/1,456
1,321 (96.3%)/
2 (0.1%)/1,372
With poor rotamers/bad
bonds/bad angles
30 (2.23%)/0/1 37 (3.26%)/0/1
With Cb deviations
>0.25 A˚/clashscore
0/5.06 (99th percentile) 1/6.99 (98th percentile)
MolProbity score 1.79 (99th percentile) 2.02 (99th percentile)
aFriedel mates were treated separately during processing for substructure solution and phasing.
bData processing values in parentheses refer to the outermost resolution shell.
cFor definitions, see Table 1 in Garcı´a-Castellanos et al. (2003).
dFor definitions, see Evans, 2006; Karplus and Diederichs, 2012.
eAverage intensity is <I/s(I)> of unique reflections after merging, according to the XDS and XSCALE programs (Kabsch, 2010).
fAccording to MolProbity (Chen et al., 2010).vicinal calcium cations separated by 10 A˚ (site 2; see Figure 5B),
which is reminiscent of the double calcium site found in the pap-
palysin family member ulilysin within metzincins (Tallant et al.,
2006). Stability provided by calcium was suggested for
B. thuringiensis InhA1 (Lo¨vgren et al., 1990) and was verified
here for BaInhA2 by thermal-shift experiments (Figure 2F). The
calcium-binding loop and the adamalysin helix surround loop
Lb7b9, which includes short strand b8 interacting with the begin-30 Structure 24, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rightsning of b9, on the upper surface of the molecule. After strand b9,
the chain enters active-site helix a8, which runs right to left and
frames the active-site cleft on its back. Helix a8 contains most of
the extended metal-binding motif, which includes zinc-binding
residues H379 and H383, and the catalytic glutamate, E380, here
mutated to alanine (see Figure 5F). The NTS-CTS transition is
G386–L387, and the third zinc-binding residue is D389 from the
CTS. Most metzincins have a histidine as third zinc ligand, butreserved
Figure 4. Crystal Structure and Topology of Pro-BaInhA2-E/A
(A and B) Structure in front view (A) and rear view (B) according to the characteristic standard orientation ofMPs. The pro-peptide is in orange, the catalytic domain
in blue (the NTS in dark blue, the CTS in cyan), the VEG domain in green, and the MAM domain in red. The C-terminal His6-tag is shown as a magenta ribbon.
Calcium, zinc, and sodium ions are shown as yellow, magenta, and blue spheres, respectively.
(C) Topology scheme of pro-BaInhA2-E/A showing the repetitive secondary structure elements and domain boundaries. Colors as in (A).
(D) Pro-BaInhA2-E/A in front and rear views as surface model for the mature enzyme moiety (domains colored as in A) and as a ribbon for the pro-peptide.
The regions of the former contributing to the interaction surface are shown in white.
(E) Close-up of the left panel of (D) showing the active-site cleft of the mature protein moiety superimposed with its electrostatic surface, ranging from
10 kcal/(mol$e) (red) over 0 kcal/(mol$e) (white) to +10 kcal/(mol$e) (blue). The MAM domain and the pro-peptide have been omitted for clarity.
See also Figure S2.aspartates have also been described for snapalysins and
igalysins (see Cerda`-Costa and Gomis-Ru¨th, 2014 and refer-
ences therein). Somemetzincins such as snapalysin and igalysin
have a tyrosine two positions downstream of the third ligand,
which may play a role in substrate binding and catalysis. It is
also present in pro-BaInhA2-E/A as Y391. Overall, the CTS is
much smaller than the NTS (56 versus 253 residues) and encom-
passes a Met-turn typical for metzincins—centered on M408—
and a C-terminal helix (a9), which leads to the end of the CD at
A442. Similarity searches with BaInhA2 CD identified the MPsStructure 24ADAM-17 (PDB: 3CKI; Maskos et al., 1998; Figure S2A) and
ulilysin (PDB: 2CKI; Tallant et al., 2006) as closest structural rel-
atives, in agreement with their common ascription to the metzin-
cins (Cerda`-Costa and Gomis-Ru¨th, 2014).
The VEG Domain of Pro-BaInhA2-E/A
After leaving the CD, the polypeptide enters an elaborate b
domain,which is reminiscent of theprincipal viral envelopeglyco-
protein from dengue virus (PDB: 3UC0; Cockburn et al., 2012;
see Figure S2B) and is hereafter dubbed the VEG domain, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 31
Figure 5. Cation Sites and Active-Site Cleft
of Pro-BaInhA2-E/A
If not otherwise stated, calcium sites are
octahedral, with oxygens at liganding distances of
2.4 ± 0.1 A˚ (typical oxygen-binding distances for
calcium span 2.36–2.39 A˚ (Harding, 2006).
(A) Site 1 calcium ion.
(B) Site 2 calcium ions.
(C) Site 3 calcium.
(D) Site 4 calcium. D536 also binds through its
second carboxylate oxygen, at 2.6 A˚.
(E) Sodium cation within the MAM domain octa-
hedrally-1 coordinated by side- and main-chain
oxygens of the protein. The binding distances are
greater than normal for sodium (2.5–3.3 A˚ versus
2.38–2.41 A˚ on average, see Harding, 2006), so it
could be a heavier cation with partial occupancy.
The site is absent from the two molecules of the
SeMet derivative.
(F) Close-up view in cross-eye stereo of the active
site of BaInhA2-E/A centered on the catalytic zinc,
with the CD as a ribbon colored according to Fig-
ures 4A and 4B (residue labels in black/light gray)
and two fragments of the pro-peptide as stick
models with carbons in orange (labels in orange).
Selected side chains are depicted. The zinc is
bound by H379Nε2, H383Nε2, D389Od1, N50N from
the pro-peptide, and a tentative acetonitrile (CCN)
nitrogen from the crystallization buffer at distances
of 2.1 ± 0.1 A˚ (typical non-sulfur ligand-binding
distances for zinc span 1.99–2.07 A˚; Harding,
2006). N93Nd2 from the pro-peptide is somewhat
farther apart (3.1 A˚).
See also Figure S2.(K443–P480 + H644–R799). It consists of a central parallel b sand-
wich (see Figures 4A–4C) made up of an upper five-stranded
mixed sheet (b10Y-b12Y-b29[-b30Y-b31+b34[) and a lower
four-stranded antiparallel sheet (b11[-b39Y-b38[-b37Y). This
central sandwich is decorated with a b ribbon, perpendicularly
grafted after the rightmost strand of the upper sheet and created
byb35+b36with the beginningof strandb37 from the lower sheet.
In addition, b35+b36 is interrupted by an insertion that comprises
helix a10, a b ribbon (b32b33), and a calcium site (site 3; see Fig-
ure 5C). In addition, 310-helix h3 is grafted onto the upper sheet
between the second and third strands from the right, and loop
Lh3b30 might contribute to shaping the rightmost edge of the
active-site cleft. The VEG domain is attached to the bottom of
the CTS (see Figures 4A–4C), mainly through its upper sheet,32 Structure 24, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reservedthrough an interface spanning 1,610 A˚2.
In addition, VEG contacts the N-terminal
segment (see above) and the end of a5
plus the downstream loop of NTS.
The MAM Domain of Pro-BaInhA2-
E/A
Grafted between the second and third
strands of the upper sheet of VEG (Fig-
ure 4C), a second b domain is laterally
attached. It displays closest structural
similarity with MAM domains, such asthe one from the human MP, meprin b (PDB: 4QWM; Arolas
et al., 2012; see Figure S2C), which in this case is grafted be-
tween two domains. The pro-BaInhA2-E/A MAM domain is a b
sandwich consisting of two five-stranded antiparallel b sheets
rotated away from each other by 25 (see Figures 4A–4C).
The sandwich consists of a back twisted sheet (b19-b18-b22-
b15+b16-b26) and a front twisted and curled sheet (b20+b21-
b17-b23+b24-b25+b14-b27). It is decorated by 310-helix h2 after
b21, a calcium site (site 4) embraced by Lb17b18 and Lb22b23
(see Figure 5D), and a b ribbon (b13b28) included in the seg-
ments in extended conformation connecting the MAM and
VEG domains. In addition, a tentative sodium site (site 5) is
shaped by Lb13b14, Lb23b24, and Lb25b26 (see Figure 5E).
While the overall architecture—including the sodium sites—of
Figure 6. Flexibility in Pro-BaInhA2-E/A
(A) Overlay of the structures of molecules A and B of native BaInhA2 and of the SeMet-derivatized protein in front (left) and lateral (right) views after superposition
of the CD and VEG domains (gray ribbons) to highlight the different relative arrangements of the MAM domains (in red, yellow, orange, and green, respectively).
Pro-peptides have been omitted for clarity. Equivalent points of the MAM domains are pinpointed by arrows for comparison. Magenta arrows indicate the
predicted hinge points, which coincide with the domain limits between VEG andMAM.Magenta, yellow, and red spheres pinpoint the catalytic zinc, calcium, and
sodium ions, respectively.
(B) The scattering-intensity curves calculated for the crystal structure of BaInhA2-E/A mutant (present work) using program CRYSOL and expanded for its
N-terminal region (20 random conformers out of 1,000 models) using the program EOM are shown in blue and cyan, respectively.pro-BaInhA2-E/A MAM and meprin b MAM are conserved, their
respective insertion into the overall multi-domain moieties is
circularly permutated and occurs through different regions (see
Figure S2C).
Function of the MAM Domain
MAM domains were initially predicted by bioinformatics, and
although their function is unknown, they have been found in
cell-surface eukaryotic proteins only and may function as
interaction or adhesion domains (Beckmann and Bork, 1993).
To explore their role in thuringilysins, we designed several
MAM-deleted variants of BaInhA1 and BaInhA2 (see Table S1).
Interestingly, all variants were insoluble or not expressed at all
in production assays with E. coli and B. subtilis as hosts, respec-
tively. Production in B. anthracis to more closely mimic their
natural environment yielded forms that lacked most of the
C-terminal VEG domains and were inactive (Figures 3C and
S1A–S1C). Removal of these C-terminal parts is likely caused
by heterolytic cleavage, since the B. anthracis strain used for
protein expression lacks MPs, but not proteases, from other cat-
alytic types (Pomerantsev et al., 2011). Overall these results
implicate theMAMdomain in folding and/or stability of InhA pep-
tidases, which affects susceptibility to (heterolytic) proteolysis.
Flexibility of the VEG-MAM Linkage
Analysis of molecular flexibility of native and SeMet-derivatized
pro-BaInhA2-E/A (respective molecules A and B) based on the
elastic network model indicated two independent rigid bodies
for the pro-peptide + CD + VEG and the MAM moieties sepa-
rately. P480–G481 and A643–H644 were identified as hinge points,
around which rearrangement through rigid-body rotation would
occur. Superposition of the four crystallographic molecules
based on the respective CD + VEG moieties revealed that
MAM domains are rearranged, but only maximally for 15 A˚ in
both the horizontal and the vertical planes (see Figure 6A).
Maximal displacement in the vertical plane was observed for
molecule A of the native structure. This correlated with the
segment connecting the globular domain of the pro-peptideStructure 24with the beginning of the CD being mostly ordered in the final
model, in contrast to the other three molecules (see above).
The overall flexibility of the VEG-MAM junction was further
analyzed in solution by SAXS using BaInhA1-HE/AA. This was
the only full-length protein variant assayed that was stable
enough over time, as assessed by SDS-PAGE (see Figure 2A)
and dynamic light scattering (DLS), and revealed a homoge-
neous protein solution (polydispersity <15%). The SAXS experi-
mental curve indicated an essentially globular protein, and
best fitting of the experimental data was obtained when the
N terminus of the crystallized protein (E33–I52) was modeled as
completely flexible (see Figure 6B). The fit, however, did not
improve significantly when including the relative arrangement
between VEG and MAM as found in the four crystal structures.
Accordingly, the hinge between these domains accounts for a
certain degree of rotational freedom but not complete flexibility.
Zymogenic and Activity Determinants in
Pro-BaInhA2-E/A
Latency is maintained in pro-BaInhA2-E/A through the pro-pep-
tide, which wraps around and interacts with the mature enzyme
moiety through a large surface of 3,450 A˚2 (Figure 4D). Regions
involved include practically the entire pro-peptide and La6a7,
Lh1b6, Lb6b7, b7, Lb7b8, La8a9, and a9 of the CD; Lb14b15
and b22 of the MAM domain; and b36 and the following loop of
the VEG domain. The globular moiety of the pro-peptide is
attached on the right side of the active-site cleft (see Figures 4A
and 4C) and introduces the preceding segment N50–Q53 in the
primed side of the cleft, thus mimicking a left-behind cleavage
product and blocking substrate access (see Figure 5F). The
a-amino group of N50 contacts the catalytic zinc ion by a zinc-
NH2 coordinative bond.With this ligand and the three zinc ligands
from the extended metal-binding motif (see above) plus a tenta-
tive acetonitrile molecule from the crystallization solution, the
metal adopts a trigonal-bipyramidal coordination. The N50 main
chain is further bound through a double interaction with
Y391Oh, which substantiates a possible role in substrate binding
during catalysis as in related MPs (see above). The side chain of, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rights reserved 33
N50, in turn, points into the S1
0 pocket, which is generally a struc-
tural element of substrate selectivity in MPs. Here, the pocket is
wide and framed by segment G410–W413 from the segment
following the Met-turn, by downstream A418–G419, and by A373–
H379 from the active-site helix. The bottomof the cleft is occupied
by S412, which binds the side-chain Od1 atom of N50. Overall, the
pocket is shaped to potentially accommodate a variety of side
chains, which is compatiblewith its broad specificity (see above).
Downstream of N50, the main-chain carbonyl of L51 binds the
side-chain Nε1 atoms of W413, the amide nitrogen of I52 binds
Y395Oh, and the side chain of Q53 is sandwiched between the
W413 and Y187 side chains. A second region of intimate contact
between the CD and the pro-peptide is provided by segment
G89–P98 of the latter. In particular, N93 approaches the metal-
binding site interacting with R336N from cleft upper-rim strand
b7 through its Od1 atom, and both zinc-ligand D389 atom Od2
and the catalytic metal through its Nd2 atom (see Figure 5F).
Downstream pro-peptide residue E95 is trapped between the
side chains of H258, H335, and R267.
Altogether, thismechanismof latency through theN terminus of
the zymogen is novel for MPs, and is distantly reminiscent of the
inhibitionmechanismof the tissue inhibitorsofmetalloproteinases
(Gomis-Ru¨th et al., 1997) andserralysin inhibitors (Baumannet al.,
1995),whichare likewiseboth inhibitedby theN-terminal segment
of the inhibitors on the primed side of the respective clefts.Conclusions
The present study documents a novel mechanism of latency
maintenance in MPs through the N terminus, which may be
shared by other BCG orthologs and paralogs from the thuringily-
sin family. Sequence analysis of the slightly more distant VcPrtV
(Figure S3) in the light of the structure of pro-BaInhA2-E/A (Fig-
ure S3), together with the recently determined NMR structure
of its isolated pro-domain (Edwin et al., 2015), point to a very
similar general architecture in Vibrio thuringilysins. They possess
two additional C-terminal domains in tandem called PKD1 and
PKD2, which are believed to participate in protein secretion
(Rompikuntal et al., 2015) and should not interfere with the pre-
ceding domains (see Figure S3). Accordingly, our conclusions
on structure, function, and activation of BaInhAs may be valid
for these relatives too.
InhA and PrtV thuringilysins evince a graftedMAMdomain that
has a role in proper expression and possibly also in protein func-
tion. So far, such domains have been found only in eukaryotes,
which suggests that BCG bacteria could have co-opted one
through horizontal gene transfer (HGT) during their intimate
coexistence with mammalian hosts and integrated it to furnish
thuringilysin peptidases. Integration would have occurred under
circular permutation of the point of insertion of the MAM domain
into preceding/succeeding domains in the respective multi-
domain structures. Similar origins through eukaryotic-to-pro-
karyotic HGT have been postulated for the bacterial MPs fragily-
sin and karilysin (Cerda`-Costa et al., 2011; Goulas et al., 2011).EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
The sequences of BaInhA1 and BaInhA2 were amplified from genomic
B. anthracis DNA and cloned into vectors pHT43 and pSW4 for extracellular34 Structure 24, 25–36, January 5, 2016 ª2016 Elsevier Ltd All rightsoverexpression in B. subtilis WB800N and B. anthracis BH460 cells, respec-
tively (for details on procedures and constructs, see Supplemental Experi-
mental Procedures and Table S1). Proteins were therefore secreted into the
extracellular medium (typically, Luria-Bertani), which contained sufficient
amounts of zinc and calcium to warrant structural and functional competence
of the MPs. E/A and HE/AA mutants of both proteins were prepared using the
QuikChange Site-Directed Mutagenesis kit and produced as the WT forms.
The SeMet variant of BaInhA2-E/A was obtained in the same way, except
that cells were grown in minimal medium supplemented with SeMet. Proteins
produced in B. subtilis and used for structural assays were purified from the
culture supernatant by two consecutive steps of immobilized metal-affinity
chromatography using first nickel-nitrilotriacetic acid resin and then TALON
resin. Proteins were finally polished by SEC in 20 mM Tris-HCl and 150 mM
NaCl (pH 7.5), and concentrated by ultrafiltration using a 10-kDa cutoff filter
device.Autolytic, Proteolytic, and Inhibitory Activity
Autolytic activation of WT and mutant BaInhA1 and BaInhA2 was monitored
over time either directly on culture supernatants or after metal-affinity purifica-
tion by SDS-PAGE and Edman sequencing. Limited proteolysis reactions of
BaInhA1-and BaInhA2-E/A mutants were performed using trypsin, chymo-
trypsin, subtilisin, and thermolysin, and subsequently analyzed by SDS-
PAGE. Cleavage activity of mature WT BaInhA1 and BaInhA2 was measured
against fluorescein conjugates (BODIPY FL casein, DQ gelatin, and DQ
BSA), natural protein substrates (actin, gelatin, collagen type I, mucin, fibro-
nectin, fibrinogen, casein, albumin, a-lactalbumin, and b-lactoglobulin), and
ten different fluorogenic peptidic substrates. The optimal pH for activity was
determined for both mature WT proteins using BODIPY FL casein as substrate
inMES (2-(N-morpholino)ethanesulfonic acid) buffer for pH 5.0–7.0; HEPES for
pH 6.0–8.0; Tris for pH 7.0–9.0; and CAPS (N-cyclohexyl-3-aminopropanesul-
fonic acid) for pH 8.0–10, respectively. Inhibition was assessed with a battery
of inhibitors of different protease classes, as well as the universal pan-protein-
ase inhibitor a2-macroglobulin, and BODIPY FL casein as substrate (see Sup-
plemental Experimental Procedures and Table S2).Conformational Stability, DLS, and SAXS Measurements
MatureWTBaInhA1 andBaInhA2were analyzed by the thermal-shift approach
in the absence and presence of either 2 mM calcium chloride or 2 mM EDTA
to determine their temperatures of mid-transition. The conformation of both
proteins, as well as of MAM-deleted variants, was assessed at 25C by far-
UV circular dichroism spectroscopy. Thermal stability of the samples was
additionally investigated by heating from 25C to 95C over time. BaInhA1-
HE/AA was characterized by DLS following standard procedures. SAXS data
of this double mutant were collected at 20C at beamline BM29 (European
Synchrotron Radiation Facility [ESRF]) and analyzed following standard
procedures.Crystallization and Structure Determination
Native and SeMet variants of zymogenic BaInhA2-E/A were crystallized at 4C
by the hanging-drop vapor diffusion method with 0.1 M Bis-Tris propane,
0.2 M sodium/potassium tartrate, and 20% (w/v) polyethylene glycol 3350
(pH 7.5) as precipitating-agent solution. Crystals were cryo-protected with
20% (v/v) glycerol, and diffraction datasets were collected at ESRF and
ALBA synchrotrons. The crystal structure of the SeMet variant was solved
by two-wavelength anomalous diffraction using a dataset collected at the ab-
sorption peak wavelength of selenium (determined by a previous XANES scan)
and a far-energy remote dataset from the same crystal. The structure of native
zymogen was solved by likelihood-scored molecular replacement. Full details
on data collection, processing, structure determination, and refinement are
given in Supplemental Experimental Procedures and Table 1.ACCESSION NUMBERS
The atomic coordinates and structure factors of the SeMet and native variants
of pro-BaInhA2-E/A have been deposited with the PDB under codes PDB:
4YU5 and 4YU6, respectively.reserved
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two tables, and three figures and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2015.10.015.
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